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in the auditory nuclei is not well defined because of the lack of 
reliable markers. The lack of information about neurotransmit-
ters, as well as the complexity of the inputs, has retarded progress 
in understanding the synaptic organization of the IC (Oliver et al., 
1999; Loftus et al., 2004).
Vesicular glutamate transporters (VGLUT) are reliable markers 
for glutamatergic terminals (Kaneko and Fujiyama, 2002), and cur-
rently three subtypes of VGLUT are known (Takamori, 2006). In 
the IC, both VGLUT1 and VGLUT2 are found in synaptic terminals 
(Kaneko et al., 2002; Altschuler et al., 2008; Ito et al., 2009), but 
VGLUT3 is not (Ito et al., 2009). Indeed, three types of glutamater-
gic terminals have been identified in the IC; terminals containing 
only VGLUT1, those containing only VGLUT2, and those contain-
ing both molecules (VGLUT1&2) (Ito et al., 2009). Certain VGLUT 
molecules in terminals seems to associate with specific patterns of 
synaptic organization: For example, the large terminals in IC tend 
to contain VGLUT1 and terminate on distal dendrites (Altschuler 
et al., 2008). In contrast, numerous, smaller VGLUT2-positive axo-
somatic terminals encircle somata of GABAergic tectothalamic cells 
(Ito et al., 2009). Therefore, elucidating the combination of VGLUT 
molecules in glutamatergic neurons which project to the IC will help 
to identify the origin of these VGLUT1- and VGLUT2-containing 
glutamatergic terminals. To identify the source of these inputs, 
we employed in situ hybridization (ISH) for VGLUT molecules 
IntroductIon
The inferior colliculus (IC) receives ascending inputs from many 
lower auditory nuclei (Whitley and Henkel, 1984; Oliver, 1985, 
1987; Saint Marie et al., 1989; Saint Marie and Baker, 1990; Oliver 
et al., 1995; Gonzalez-Hernandez et al., 1996; Alibardi, 1998; Cant 
and Benson, 2006) and descending inputs from the auditory cortex 
(Winer et al., 1998). In spite of the number of studies about neuro-
transmitters used in these pathways (Saint Marie et al., 1989; Saint 
Marie and Baker, 1990; Gonzalez-Hernandez et al., 1996; Alibardi, 
1998), the expression of neurotransmitters, especially glutamate, 
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Terminals containing vesicular glutamate transporter (VGLUT) 2 make dense axosomatic 
synapses on tectothalamic GABAergic neurons.  These are one of the three types of glutamatergic 
synapses in the inferior colliculus (IC) identified by one of three combinations of transporter 
protein: VGLUT1 only, VGLUT2 only, or both VGLUT1 and 2. To identify the source(s) of these 
three classes of glutamatergic terminals, we employed the injection of Fluorogold (FG) into the 
IC and retrograde transport in combination with in situ hybridization for VGLUT1 and VGLUT2 
mRNA.  The distribution of FG-positive soma was consistent with previous reports. In the auditory 
cortex, all FG-positive cells expressed only VGLUT1. In the IC, the majority of FG-positive cells 
expressed only VGLUT2. In the intermediate nucleus of the lateral lemniscus, most FG-positive 
cells expressed VGLUT2, and a few FG-positive cells expressed both VGLUT1 and 2. In the 
superior olivary complex (SOC), the majority of FG-positive cells expressing VGLUT2 were in the 
lateral superior olive, medial superior olive, and some periolivary nuclei. Fewer FG-positive cells 
expressed VGLUT1&2. In the ventral cochlear nucleus, almost all FG-positive cells expressed 
VGLUT1&2. On the other hand in the dorsal cochlear nucleus, the vast majority of FG-positive 
cells expressed only VGLUT2. Our data suggest that (1) the most likely sources of VGLUT2 
terminals in the IC are the intermediate nucleus of the lateral lemniscus, the dorsal cochlear 
nucleus, the medial and lateral superior olive, and the IC itself, (2) VGLUT1 terminals in the IC 
originate only in the ipsilateral auditory cortex, and (3) VGLUT1&2 terminals in IC originate mainly 
from the VCN with minor contributions from the SOC and the lateral lemniscal nuclei.
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  combined with the retrograde transport and immunohistochemical 
detection of Fluorogold (FG) after the large injection of FG into the 
IC. Neurons expressing VGLUT mRNA exhibit whole population 
of glutamatergic neurons and large FG injection into the IC reveals 
neural population making projection to the IC. Therefore, this 
approach is useful to show the sources of IC VGLUT terminals.
MaterIals and Methods
subjects
Fourteen adult Long-Evans rats were used for this study. All experi-
ments were done in accordance with institutional guidelines at 
the University of Connecticut Health Center and in accordance 
with NIH guidelines for the care and use of laboratory animals. 
All efforts were made to minimize the number of animals used 
and their suffering.
survIval surgery
Rats were anesthetized with ketamine (97.5 mg/kg i.m.) and xyla-
zine (2.4 mg/kg i.m.), and maintained in an areflexive state with 
isoflurane mixed with oxygen for the duration of the surgery and 
recording. Surgery and recording were done in a double-walled 
sound attenuating chamber (IAC, Bronx, NY, USA). Acoustic stimuli 
were generated by a TDT System 2 (Tucker Davis Technologies, 
Gainesville, FL, USA) under the control of a PC computer and 
custom software. All sounds were delivered by Beyer earphones 
(DT-48, Hicksville, NY, USA) via sealed enclosures. Animals were 
fixed in a stereotaxic apparatus that incorporated hollow ear bars 
to deliver sound stimuli. The sound delivery system was calibrated 
from 60 to 40,000 Hz, and the calibration was performed at the 
end of the ear bar with a 1/8′ microphone (Brüel & Kjær, Nærum, 
Denmark). A craniotomy opened the right parietal bone over the 
visual cortex. Glass micropipettes (4–7 μm tip, 0.5–5 MΩ) were filled 
with 3% FG (Fluorochrome, Denver, CO, USA) diluted in saline. 
These glass electrodes were advanced with a microdrive (Burleigh 
Inchworm, Fishers, NY, USA) mounted on the stereotaxic manipu-
lator through the cortex after the dura was opened. Recordings of 
activity evoked by sounds in the contralateral ear were used to locate 
the IC. Acoustically driven responses of single or multiple units were 
amplified with a Dagan 2400 amplifier (Minneapolis, MN, USA) 
and a low noise amplifier (Princeton Applied Research, model 5113 
amplifiers). Neurons in the central nucleus of the IC (ICC) were 
identified by short latency responses to white noise bursts or pure 
tones. At locations in the IC with brisk responses, FG was iontopho-
retically injected from the recording pipette with a 2–5 μA current 
for durations of 2–5 min with a 50% duty cycle (7 s on/7 s off).
Four to seven days after the surgery, the rats were deeply anes-
thetized with ketamine (97.5 mg/kg i.m.) and xylazine (2.4 mg/
kg i.m.), and perfused transcardially with 4% paraformaldehyde 
in 0.1 M phosphate buffer (PB, pH 7.4). After cryoprotection in 
30% sucrose in PB for 2 days, serial, 40 μm-thick, coronal sections 
were cut with a freezing microtome. A series of every fifth section 
was used for histology.
IMMunohIstocheMIstry for fg
We  used  a  rabbit  polyclonal  antibody  to  detect  FG  (AB153, 
Millipore). Specificity of the antibody was confirmed by absence 
of staining in tissues which did not contain FG. Sections were 
incubated with the rabbit anti-FG antibody (1:8000) diluted in 
0.3% Triton X-100 with 1% normal goat serum in 0.05 M phos-
phate-buffered saline (PBS-XG), followed by an incubation in a 
biotinylated goat anti-rabbit secondary antibody (1:200; Vector 
Laboratories, Burlingame, CA, USA) diluted in PBS-XG. After 
an incubation in avidin-biotinylated peroxidase complex (1:50; 
ABC-Elite, Vector) in PBS containing 0.3% Triton X-100 (PBS-X), 
sections were processed for a Nickel-diaminobenzidine (DAB) reac-
tion. Sections were mounted on coated glass slides, counterstained 
with Neutral Red (Fisher Scientific, Fair Lawn, NJ, USA), dehy-
drated through graded alcohols, cleared with Histoclear (National 
Diagnostics, Atlanta, GA, USA), and coverslipped with Permount 
(Fisher Scientific, Waltham, MA, USA).
brIghtfIeld Ish coMbIned wIth IMMunohIstocheMIstry for fg
Both digoxigenin (DIG)- and fluorescein (FL)-labeled antisense 
riboprobes were made from cDNAs of mouse VGLUT1 (nucle-
otides of 152–1085, GenBank accession number NM_182993.2) 
and mouse VGLUT2 (nucleotides of 848–2044, GenBank acces-
sion number NM_080853.2). The specificity of the riboprobes 
for VGLUT1 and VGLUT2 was established in previous studies 
(Watakabe et al., 2006; Nakamura et al., 2007). Furthermore, the 
sequences of VGLUT1, VGLUT2 probes have very high similari-
ties with corresponding regions of the rat cDNAs (96 and 94%, 
respectively). On the other hand, similarities of these riboprobes 
with other members of the family of molecules are low: The mouse 
VGLUT1 riboprobe shares only 74 and 71% identity with the cor-
responding regions of the rat VGLUT2 and VGLUT3 mRNA; and 
the mouse VGLUT2 riboprobe has only 74 and 76% homology 
with the rat VGLUT1 and VGLUT3 mRNA.
All 14 animals were processed for non-radioactive ISH. The 
procedure for non-radioactive ISH was described previously (Liang 
et al., 2000; Ito et al., 2007, 2008). Free-floating sections were washed 
in 0.1 M PB (pH 7.0) for 5 min twice, immersed in PB contain-
ing 0.3% Triton X-100, and rinsed in 0.1 M PB. Then, sections 
were acetylated for 10 min at room temperature with 0.003% ace-
tic acid anhydrate, 1.3% (v/v) triethanolamine, and 6.5% (w/v) 
HCl diluted in DEPC-treated water. After being rinsed in 0.1 M 
PB twice, the sections were incubated for 1 h at 70°C in a pre-
hybridization buffer containing 50% (v/v) formamide, 5 × SSC 
buffer (a 5× concentration of SSC buffer containing 16.65 mM 
sodium chloride and 16.65 mM sodium citrate buffer, pH 7.0), 
2% blocking reagents (Roche Diagnostics, Mannheim, Germany), 
0.1% N-lauroylsarcosine (NLS), and 0.1% sodium dodecyl sulfate. 
Then, the sections were hybridized with 1 μg/ml DIG-labeled sense 
or antisense RNA probe for VGLUT1 or VGLUT2 in freshly pre-
pared prehybridization buffer for 20 h at 70°C. After two washes 
in 2× SSC, 50% formamide, and 0.1% NLS for 20 min at 70°C, 
the sections were rinsed in 2× SSC with 0.1% NLS for 20 min 
twice at 37°C, and in 0.2× SSC with 0.1% NLS for 20 min twice 
at 37°C. These sections were incubated with 1% blocking reagent 
(Roche) diluted in Tris–HCl (pH 7.5) and 0.15 M NaCl (TS7.5) 
for 1 h at room temperature, and then with alkaline phosphatase-
conjugated anti-DIG antibody Fab fragment (1:2000; Roche) and 
rabbit anti-FG antibody (1:8000) in 1% blocking reagent (Roche) 
diluted in TS7.5 at room temperature overnight. After the second-
ary and ABC reactions described above, FG was visualized by a DAB Frontiers in Neuroanatomy  www.frontiersin.org  September 2010  | Volume 4  | Article 135  |  3
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FG-positive cells were assembled on the trace. The nuclei were 
identified  by  Nissl  cytoarchitecture,  and  in  accordance  with 
Mugnaini et al. (1980) for the cochlear nuclei complex (CNC), 
Schofield and Cant (1991) for the superior olivary complex (SOC), 
Saint Marie et al. (1997) for the nuclei of the lateral lemniscus 
(NLL), and Loftus et al. (2008) for the IC.
results
InjectIon sItes
The injection was restricted to the IC in all 14 cases. In nine cases, 
the injection site was mainly in the ICC. In two cases, the injec-
tion site was in the lateral cortex of the IC (LC). In three cases, the 
injection was made around the border of the ICC and LC. Double 
fluorescent ISH combined with FG immunohistochemistry was 
performed in three cases, and those injection sites were in the ICC 
(08-110; Figure 1A) and the border of the ICC and LC (08-118 
and 08-124; Figures 1B,C).
reaction. Subsequently, the bound phosphatase was visualized by a 
reaction with nitro blue tetrazolium chloride/5-bromo-4-chloro-3-
indolyl phosphate toluidine salt (Roche) for 4 h at 37°C in Tris–HCl 
(pH 9.5), 0.15 M NaCl, and 10 mM MgCl2. Finally, the sections were 
mounted on coated glass slides, dehydrated, cleared with Histoclear 
(National Diagnostics, Atlanta, GA, USA), and coverslipped.
double fluorescent Ish coMbIned wIth 
IMMunohIstocheMIstry for fg
In three rats that showed the strongest signals in brightfield ISH, 
brainstem sections were also processed for a combination of fluo-
rescent ISH and FG immunohistochemistry. For fluorescent ISH 
to detect VGLUT1 and VGLUT2 expression, the FL-labeled ribo-
probe for VGLUT1 and DIG-labeled riboprobe for VGLUT2 were 
diluted in hybridization buffer at a final concentration of 1 μg/ml. 
The hybridization temperature was set at 70°C. After the incuba-
tion and washing described above, these sections were incubated 
with alkaline phosphatase-conjugated sheep anti-FL antibody Fab 
fragment (1:2000; Roche), peroxidase-conjugated sheep anti-DIG 
antibody Fab fragment (1:2000; Roche), and rabbit anti-FG (1:1000) 
in 1% blocking reagent (Roche) diluted in TS7.5 at room tempera-
ture overnight. The sections were rinsed three times, and then the 
bound peroxidase was reacted with dinitrophenol-tyramide signal 
amplification (Perkin-Elmer, Waltham, MA, USA). After three more 
washes, the sections were incubated with AlexaFluor 488-conjugated 
goat anti-rabbit IgG (1:100; Invitrogen, Carlsbad, CA, USA), blocked 
by 10% normal rabbit serum, and then incubated with AlexaFluor 
647-conjugated rabbit anti-dinitrophenol (1:50; Invitrogen) diluted 
in 1% normal rabbit serum/TS7.5. To visualize bound alkaline phos-
phatase by fluorescent microscopy, sections were developed with 
0.005%  (w/v)  4-chloro-2-methylbenzenediazonium  hemi-zinc 
chloride (Fast Red TR, Roche), 1% (v/v) 2-hydroxy-3-naphthoic 
acid-2′-phenylanilide phosphate (HNPP, Roche) diluted in 0.1 M 
Tris–HCl (pH 8.0), 0.15 M NaCl, 10 mM MgCl2, for 30 min at room 
temperature. The sections were mounted on glass slides with CC/
Mount (DBS, Pleasanton, CA, USA).
IMage analysIs
Fluorescent images were acquired with a laser scanning confocal 
microscope (Zeiss 510 META, Carl Zeiss Microimaging, Göttingen, 
Germany) or structural illuminated microscope (Zeiss Axiovert 
microscope with Apotome, Zeiss). For the laser scanning confocal 
microscopy, AlexaFluor 488 was excited by a 488 nm Ar laser, and 
emitted fluorescence was filtered with a 500–530 nm band-pass 
filter. Fast Red was excited by a 543-nm He–Ne laser, and emit-
ted fluorescence was filtered with a 565–615 nm band-pass filter. 
AlexaFluor 647 was excited by a 633-nm He–Ne laser, and emitted 
fluorescence was filtered with a 650-nm low-pass filter. Images of 
each dye were taken sequentially to avoid bleed-through artifact. 
For structural illuminated microscopy, filter sets for FITC, rhod-
amine, and Cy5 were used to visualize AlexaFluor 488, FastRed, and 
AlexaFluor 647, respectively. Minimal adjustments of the levels were 
made by Photoshop CS3 (Adobe Systems, San Jose, CA, USA).
To  plot  FG-immunofluorescent  cells,  we  took  images  of 
FG-positive cells with a ×10 lens (NA 0.5). Outlines of the evenly 
spaced (200 μm) serial sections were traced with Neurolucida 
(MBF Bioscience, Inc., Williston, VT, USA), and the images of 
Figure 1 | injection sites of Fg. Top images show the center of the injection 
site in three animals processed for fluorescent ISH. Line drawings show the 
full extent of the injection sites (gray) at several rostro-caudal levels. In case 
08-110 (A), the injection is almost restricted to the central nucleus (ICC). In 
cases 08-118 (B) and 08-124 (C), the injections are larger, and they cover both 
the lateral cortex (LC) and lateral part of the ICC. Numbers indicate the 
distance (in millimeters) from the section which contains the most rostral part 
of the ventral nucleus of the lateral lemniscus (VNLL). Note that in the case 
08-110, two injections were made. Scale bar: 1 mm.Frontiers in Neuroanatomy  www.frontiersin.org  September 2010  | Volume 4  | Article 135  |  4
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MIdbraIn
The main source of VGLUT2 inputs to the IC from the midbrain 
was the contralateral IC and the ipsilateral INLL. The majority 
of the retrogradely labeled cells in the IC were located in the 
contralateral central nucleus (Figure 2A). We found numerous 
neurons expressing VGLUT2 but none that expressed VGLUT1. 
VGLUT2  was  expressed  in  around  90%  of  FG-positive  cells 
in the central nucleus and lateral cortex (Table 2) and in over 
70% of FG-positive neurons in dorsal cortex (Table 2). No neu-
rons  expressed  VGLUT1  or  VGLUT1&2  (Figures  2B,3A1–4; 
Tables 1,2). The FG-labeled cells without VGLUT expression 
are likely the GABAergic neurons. So, both glutamatergic and 
GABAergic neurons have projections through the commissure 
of the IC.
The  INLL  also  had  significant  numbers  of  FG-labeled, 
VGLUT2-expressing  cells.  Fewer  FG-labeled  cells  expressed 
VGLUT1&2. Both patterns were found throughout the nucleus 
(Figure 2B, sections 0.4–1.4). Over 50% of FG-positive cells in the 
ipsilateral INLL expressed VGLUT2 (white arrows in Figure 3C). 
Around 20% of retrogradely labeled cells co-expressed VGLUT1&2 
(black arrows in Figure 3C). The morphology was very similar for 
the FG-positive cells that expressed VGLUT1&2 or VGLUT2 alone 
(Figure 3C) and project to the IC.
overvIew of retrograde labelIng and vglut gene expressIon
The combined analysis of retrograde FG-labeling and gene expres-
sion for VGLUT revealed four patterns of retrogradely labeled neu-
rons. Some retrogradely FG-labeled neurons expressed the gene 
for VGLUT2 only (VGLUT2 in the text; FG+/V1−/V2+ in the fig-
ures and tables). Others co-expressed both VGLUT1 and VGLUT2 
(VGLUT1&2 in the text; FG+/V1+/V2+ in the figures and tables). The 
third pattern was FG-labeling and the absence of either VGLUT1 or 
VGLUT2 gene expression (FG+/V1−/V2− in the figures and tables). 
This is most likely associated with neurons that use GABA or glycine 
as a neurotransmitter. These first three patterns were prevalent in 
the auditory midbrain, pons, and medulla. FG-labeling with gene 
expression of VGLUT1 alone was not seen in these regions. However, 
in the auditory cortex the only pattern observed was FG-labeled 
neurons that expressed only VGLUT1 (VGLUT1 in the text). In all 
cases, FG-retrogradely labeled cells were found in the contralateral 
IC, bilaterally in the dorsal NLL (DNLL), ipsilaterally in the inter-
mediate and ventral NLL (INLL and VNLL), bilaterally in the SOC, 
and contralaterally in the CNC. Four cases had bilateral FG retro-
grade label in the auditory cortex. The general pattern of retrograde 
labeling was consistent with previous studies (Beyerl, 1978; Coleman 
and Clerici, 1987; Herbert et al., 1991; Saldana and Merchan, 1992; 
Gonzalez-Hernandez et al., 1996; Oliver et al., 1999).
Figure 2 | Plots of retrogradely labeled cells in the iC (A), NLL, SOC, and 
CNC (B) of the case 08-118. In the IC (A), contralateral side to the injection site 
was presented. Red dots indicate cells positive for both FG and VGLUT2 but 
negative for VGLUT1 (FG+/ V1−/ V2+). Green dots indicate cells positive for all 
three molecules (FG+/ V1+/ V2+). Blue dots indicate cells positive for FG but 
negative for VGLUT1 and VGLUT2 (FG+/ V1−/ V2−). Numbers indicate the 
distance (in millimeter) from the section which contains the most rostral part of 
the VNLL. Scale bar: 2 mm.Frontiers in Neuroanatomy  www.frontiersin.org  September 2010  | Volume 4  | Article 135  |  5
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the FG-positive cells (99%) co-expressed VGLUT1&2 in the AVCN 
(Figure 3E) and PVCN (Figure 3F). These were likely to be T-stellate 
cells with projections to the IC (Oliver, 1987; Oertel et al., 1990; Oliver 
et al., 1999). In contrast, the large cells in the DCN mainly found in 
layer 2 expressed only VGLUT2, and only these, presumably fusiform 
cells, were labeled with FG (Figure 3G). This is consistent with pre-
sumed glutamatergic inputs to the IC from these cells (Adams, 1979; 
Oliver, 1984a). No other neurons were FG-labeled including the small 
granule cells that were positive for only VGLUT1 (Figure 3G2).
superIor olIvary coMplex
In general, the IC projections from the SOC followed either the LSO 
pattern, the MSO pattern, or the SPO pattern. The LSO pattern 
was a mixture of VGLUT expression on the contralateral side and 
In the DNLL, expression of either VGLUT was rare (Figure 2B, 
sections 0.4–1.4; Figure 3B). We found that VGLUT negative neurons 
comprised over 90% of FG-labeled neurons in the contralateral and 
ipsilateral side, respectively (Table 2). Most likely, these are GABAergic 
neurons. A similar pattern was seen in the ventral part of the lateral 
lemniscus where the expression of VGLUT was rare. Over 90% of 
VNLL retrogradely labeled cells were not positive for VGLUT1 or 
VGLUT2 (Figure 2B, sections 0.4 and 0.8; Figure 3D). These are likely 
GABAergic and/or glycinergic neurons with projections to the IC.
cochlear nucleus
Most FG-labeled neurons in the cochlear nucleus were found on 
the contralateral side, but the patterns in AVCN and PVCN were 
different from the DCN (Figure 2B, sections 2.0–4.0). Almost all 
Figure 3 | Fluorescent micrographs of retrogradely labeled cells in the iC (A), NLL (B–D), CNC (e–g), and SOC (H–Q). Some retrogradely labeled cells 
expressed only VGLUT2 (white arrows) or both VGLUT1 and VGLUT2 (black arrows). The “c” and “i” after the abbreviation of the nuclei mean contralateral and 
ipsilateral to the injection site. Green: VGLUT2; red: VGLUT1; blue: FG. Scale bar: 50 μm.Frontiers in Neuroanatomy  www.frontiersin.org  September 2010  | Volume 4  | Article 135  |  6
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In  the  LSO  pattern, VGLUT2  or VGLUT1&2  expression  in 
FG-labeled neurons was seen on the contralateral side, and a lack 
of VGLUT expression was seen on the ipsilateral side. The DPO 
(Figure 2B, sections 1.0–2.2; Figure 3K), the LVPO (Figure 2B, 
sections 1.0–2.2; Figures 3L,M), and the RPO (Figure 2B, sections 
0.4–1.0; Figure 3P) followed the general LSO pattern. However, they 
tended to have fewer FG-labeled VGLUT2 or VGLUT1&2 express-
ing neurons on the contralateral side (Table 1) and FG-positive cells 
expressed neither VGLUT gene on the ipsilateral side (Table 2). Thus, 
this pattern provides mixed glutamatergic and non-  glutamatergic 
inputs to the IC with a predominant inhibitory input from the 
ipsilateral side.
In the MSO, almost all FG-positive cells expressed VGLUT2 on 
the ipsilateral side. About half of these co-expressed VGLUT1&2 
(Table 2; black arrowheads in Figure 3J). Both types of neurons 
were located throughout the nucleus (Figure 2B, sections 1.2–2.2) 
non-VGLUT expression on the ipsilateral side. The MSO pattern 
was predominantly an ipsilateral projection that was exclusively 
VGLUT-positive. The SPO pattern was also an ipsilateral projection, 
but it was exclusively non-glutamatergic (Table 2).
In  the  contralateral  LSO,  all  FG-positive  cells  expressed 
VGLUT2 (Table 2; white arrows in Figure 3H). About 20% co-
expressed VGLUT1&2. The morphology of these two types of 
FG-positive cells was similar (Figure 3I). Cells expressing both 
molecules were located throughout the nucleus (Figure 2B, sec-
tions 1.6–2.2) and represent an exclusively glutamatergic con-
tralateral LSO projection. In the ipsilateral LSO, to the contrary, 
99% of the hundreds of FG-positive cells were negative for both 
VGLUT1 and VGLUT2 (Table 2; Figure 3I). Thus, the ipsilat-
eral LSO projection is probably exclusively glycinergic, and a 
glutamatergic input to the ipsilateral IC from LSO appears to 
be absent in the rat.
Figure 3 | ContinuedFrontiers in Neuroanatomy  www.frontiersin.org  September 2010  | Volume 4  | Article 135  |  7
Ito and Oliver  Origins of IC glutamatergic terminals
This pattern was seen in the SPO (Figure 2B, sections 1.0–2.2) 
and the MVPO (Figure 2B, sections 0.8–2.2). In SPO, over 96% 
of FG-positive cells were negative for VGLUT1 and/or VGLUT2 
(Table 2; Figure 3Q). Likewise, in the MVPO there were almost 
no VGLUT-expressing, FG-positive neurons found on the ipsilat-
eral side (Table 1; Figure 3N). These data suggest both SPO and 
MVPO function exclusively as ipsilateral inhibitory inputs to IC. 
Interestingly, this is similar to the pattern seen for the VNLL, non-
glutamatergic inputs to ipsilateral IC. Both VNLL and these perio-
livary nuclei may receive excitatory inputs from the   contralateral 
cochlear nucleus.
and were flat-shaped and densely packed in the dorso-ventral 
axis. Thus, at least 97% of the ipsilateral MSO projection to IC is 
glutamatergic.
The MSO pattern emphasizes the ipsilateral glutamatergic input 
to IC. The VMPO follows the MSO pattern (Figure 2B, sections 
1.2–2.2). FG-positive cells were mainly found on the ipsilateral 
side, and most of them colocalized VGLUT2. The majority of 
FG-positive cells co-expressed VGLUT1&2 (Table 2). Both VGLUT2 
and VGLUT1&2 cells had similar morphology (Figure 3O).
In the SPO pattern, VGLUT expression was rare and most pro-
jections to IC were ipsilateral.
Table 1 | The percentage and number of Fg-positive neurons that express VgLuT1 (V1) and/or VgLuT2 (V2).
  Percentage Fg+ neurons
Case #  08-110  08-118  08-124
Nucleus  V1−/V2+  V1+/V2+  V1−/V2−  N  V1−/V2+  V1+/V2+  V1−/V2−  N  V1−/V2+  V1+/V2+  V1−/V2− N
iC
LCc  86.1    13.9  36  94.8    5.2  97  86.7    13.3  165
ICCc  90.7    9.3  129  89.4    10.6  216  93.2    6.8  414
DCc  62.5    37 .5  8  90.9    9.1  22  77 .8    22.2  63
NLL
DNLLc  6.3    93.8  16  0.4    99.6  228  1.0  0.3  98.6  296
DNLLi  7 .7    92.3  26  9.3  1.4  89.3  140  1.1  4.3  94.7  188
INLLi  67 .0  9.4  23.6  106  58.2  19.9  22.0  428  53.7  31.8  14.4  471
VNLLi  2.3  1.5  96.1  389  6.4  1.7  91.9  470  4.2  2.1  93.6  1083
SOC
DPOc    100.0    3  90.9  9.1    11  80.0  10.0  10.0  10
DPOi      100.0  3  10.5    89.5  19  16.0  4.0  80.0  25
LSOc  78.8  21.2    52  74.4  25.6    195  83.7  16.3    166
LSOi      100.0  4  1.6    98.4  306  0.3  0.3  99.3  293
LVPOc    100.0    2  51.3  46.2  2.6  78  70.7  28.0  1.3  75
LVPOi    12.5  87 .5  16  5.0  2.8  92.2  141  10.0  13.0  77 .0  200
MNTBi      100.0  1      100.0  1      100.0  4
MSOc        0  60.0  20.0  20.0  5  42.9  57 .1    7
MSOi  30.8  61.5  7 .7  13  66.4  33.6    223  52.3  46.5  1.2  172
MVPOc        0      100.0  1  100.0      1
MVPOi      100.0  11      100.0  75      100.0  84
RPOc        0        0  60.0  20.0  20.0  5
RPOi    9.1  90.9  11  12.8  35.9  51.3  39  12.2  4.9  82.9  41
SPOc      100.0  1      100.0  2  20.0    80.0  5
SPOi  3.4  3.4  93.1  29  4.6  0.6  94.9  175      100.0  151
VMPOc        0  60.0  30.0  10.0  10  60.0  20.0  20.0  5
VMPOi  33.3  66.7    3  24.7  67 .4  7 .9  89  25.0  67 .9  7 .1  28
CNC
AVCNc    100.0    312  1.8  98.2    541  0.8  99.2    485
AVCNi    100.0    1    100.0    8    100.0    3
DCNc  98.4  1.6    245  99.1  0.6  0.3  344  97 .9  1.1  1.1  285
DCNi  100.0      1  84.6  15.4    13  77 .8    22.2  9
PVCNc  0.7  99.3    140  1.9  97 .7  0.4  258    100.0    262
PVCNi        0        0    100.0    7
All nuclei  34.0  33.8  32.2  1558  39.5  33.0  27 .4  4135  47 .4  30.2  22.4  5003
c, contralateral; i, ipsilateral. See list of abbreviations.Frontiers in Neuroanatomy  www.frontiersin.org  September 2010  | Volume 4  | Article 135  |  8
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those with only the VGLUT2 protein, those with only the VGLUT1 
protein, and those with both proteins (Ito et al., 2009). Neither 
terminals nor soma positive for VGLUT3 were found in the IC 
(Ito et al., 2009). The present data offer new information about 
the origins of these terminals. The VGLUT1 terminals in the IC 
most likely arise from pyramidal cells in the auditory cortex since 
that is the predominant gene expressed in cortex. The IC terminals 
that contain GABA or glycine are highly likely to come from the 
FG-positive cells that lack VGLUT1 and VGLUT2 expression. The 
IC terminals that contain VGLUT1 and VGLUT2 proteins most 
likely come from the neurons that express both genes, and this pat-
tern is most prevalent in the ventral cochlear nucleus. The VGLUT2 
terminals constitute the largest number of terminals in the IC. It is 
of interest because it is the only type of terminal that makes dense 
axosomatic and axodendritic terminals on the large GABAergic 
tectothalamic neurons (Ito et al., 2009). However, there are multiple 
inputs that could be the source of these terminals.
possIble sources of axosoMatIc vglut2 terMInals In Ic
Our data demonstrate that possible sources of VGLUT2 terminals in 
the IC are the contralateral LSO and DCN and the ipsilateral INLL, 
MSO, and VMPO. Each of these sources is also a potential source 
for the axosomatic VGLUT2 terminals on the large GABAergic 
neurons in the IC. In addition, the local axons of IC neurons from 
the both the ipsilateral and contralateral sides are possible sources 
of VGLUT2 axosomatic terminals. Most IC neurons make local 
axonal collaterals (Oliver et al., 1991) and many project contralat-
erally through the commissure to the opposite side (Saldana and 
Merchan, 1992). These multiple sources of VGLUT2 may make 
audItory cortex
In the ipsilateral AC, numerous neurons were retrogradely labeled 
with FG and expressed VGLUT1 (Figure 4A). We examined the 
cortex in four cases that underwent non-florescent ISH and found 
that most retrogradely labeled cells were in layer 5 and expressed 
only VGLUT1 (Figure 4C). In contrast, FG-labeled cells did not 
express VGLUT2 (Figures 4B,D). VGLUT2 expression in the cortex 
was slightly above the background level in layer 2–4 and moder-
ate in layer 6 in the rostral AC (Figures 5A,B), which is consistent 
with previous studies (Hisano et al., 2000; De Gois et al., 2005). 
This weak expression of VGLUT2 in the cortex was in contrast to 
the strong expression in the thalamus seen in the same section 
(Figure 5C). Since all FG-positive cells expressed only VGLUT1, 
we did not count the FG-labeled cells or calculate the percentage 
of VGLUT in FG-labeled cells.
dIscussIon
These results suggest the origins of both excitatory and inhibitory 
terminals in the IC. In the IC, putative glutamatergic terminals 
contain VGLUT1 and/or VGLUT2 (Altschuler et al., 2008; Ito et al., 
2009). Three kinds of glutamatergic terminals are seen in the IC, 
Table 2 | Mean percentage and standard deviation of all Fg-positive 
cells that express VgLuT1 (V1) and VgLuT2 (V2) calculated from the 
three cases in Table 1.
  Mean of Fg+ neurons (% ± SD)
Nucleus  V1−/V2+  V1+/V2+  V1−/V2−
iC
LCc  89.2 ± 4.9  0.0 ± 0.0  10.8 ± 4.9
ICCc  91.1 ± 2.0  0.0 ± 0.0  8.9 ± 2.0
DCc  77 .1 ± 14.2  0.0 ± 0.0  22.9 ± 14.2
NLL
DNLLc  2.6 ± 3.2  0.1 ± 0.2  97 .3 ± 3.1
DNLLi  6.0 ± 4.4  1.9 ± 2.2  92.1 ± 2.7
INLLi  59.6 ± 6.8  20.4 ± 11.2  20.0 ± 4.9
VNLLi  4.3 ± 2.0  1.8 ± 0.3  93.9 ± 2.1
SOC
DPOi  8.8 ± 8.1  1.3 ± 2.3  89.8 ± 10.0
LSOc  79.0 ± 4.7  21.0 ± 4.7  0.0 ± 0.0
LSOi  0.7 ± 0.9  0.1 ± 0.2  99.2 ± 0.8
LVPOc  40.6 ± 36.5  58.1 ± 37 .4  1.3 ± 1.3
LVPOi  5.0 ± 5.0  9.4 ± 5.7  85.6 ± 7. 8
MSOi  49.8 ± 17 .9  47 .2 ± 14.0  3.0 ± 4.1
MVPOi  0.0 ± 0.0  0.0 ± 0.0  100.0 ± 0.0
RPOi  8.3 ± 7 .2  16.6 ± 16.8  75.0 ± 21.0
SPOi  2.7 ± 2.4  1.3 ± 1.8  96.0 ± 3.6
VMPOi  27 .7 ± 4.9  67 .3 ± 0.6  5.0 ± 4.3
CNC
AVCNc  0.9 ± 0.9  99.1 ± 0.9  0.0 ± 0.0
DCNc  98.5 ± 0.6  1.1 ± 0.5  0.4 ± 0.5
PVCNc  0.9 ± 1.0  99.0 ± 1.2  0.1 ± 0.2
All nuclei  32.3 ± 1.9  27 .4 ± 4.9  40.3 ± 6.7
Nuclei that have more than 10 mean cell counts are presented.
Figure 4 | Corticofugal neurons in layer 5 (V) express only VgLuT1. 
Brightfield ISH for VGLUT1 (A,C) or VGLUT2 (B,D) combined with 
immunohistochemistry for FG showed that retrogradely labeled pyramidal 
neurons express VGLUT1 but not VGLUT2. (C,D) Are the higher magnification 
of boxes in (A,B), respectively. Scale bars: 500 μm (A,B), and 50 μm (C,D).Frontiers in Neuroanatomy  www.frontiersin.org  September 2010  | Volume 4  | Article 135  |  9
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different types of terminals in the IC. For example, some VGLUT2 
terminals synapse on small, distal dendrites (Altschuler et al., 2008; 
Ito et al., 2009), and these may not be from the same source as the 
dense VGLUT2 axosomatic terminals. Some DCN terminals with 
round synaptic vesicles make asymmetric axosomatic synapses on 
large IC cells in the cat (Oliver, 1984a, 1985). So, DCN neurons 
expressing VGLUT2 may be the source of some of the VGLUT2 
axosomatic terminals on the large GABAergic IC neurons. Indeed, 
the GABAergic neurons are the largest IC cells in the cat (Oliver 
et al., 1994) similar to the rat (Ito et al., 2009).
It is unlikely that a single axon forms all of the axosomatic 
VGLUT2 terminals that surround the soma of the large GABAergic 
IC cells in the IC (Ito et al., 2009). Calyx- or endbulb-like terminals 
have not been seen in the IC in Golgi preparations or in anterograde 
transport experiments (Morest and Oliver, 1984; Oliver, 1984b; 
Oliver et al., 1991, 1999). These endings may come from a single 
brainstem nucleus or multiple nuclei.
Cells with axosomatic VGLUT2-positive terminals are distrib-
uted in all parts of the IC (Ito et al., 2009). This suggests that if a 
single nucleus supplies all the axosomatic VGLUT2 endings, the 
most likely source is a nucleus where retrogradely FG-labeled cells 
are always numerous regardless of the location of the injection 
site in the IC. Using this logic, our data suggest that the MSO and 
LSO are unlikely candidates for a single source since the number 
of retrogradely labeled cells in those nuclei varied dramatically 
between cases, while the number of retrogradely labeled cells in 
the other nuclei was consistently high. Only 4/14 cases (including 
08-118 and 08-124) in which injections were made in lateral ICC 
have large numbers of retrogradely labeled cells in the LSO and 
MSO. These results are consistent with the findings in the gerbil 
(Cant and Benson, 2006) where the number of retrogradely labeled 
cells in the LSO and MSO were few when injections were made 
into the medial central nucleus. On the other hand, if the VGLUT2 
axosomatic endings are formed by terminals from multiple sources, 
we cannot exclude any of the nuclei.
One population of IC terminals contained both VGLUT1 and 
VGLUT2 proteins, and this suggests one or more source expressing 
both genes. Since axosomatic endings on large IC GABAergic neu-
rons express only VGLUT2 (Altschuler et al., 2008; Ito et al., 2009), 
it is unlikely that nuclei with neurons expressing VGLUT1&2 will 
be the sources of the dense axosomatic synapse. The percentage of 
neurons expressing VGLUT1&2 was larger than VGLUT2 alone in 
the AVCN, PVCN, LVPO, and VMPO. Since AVCN and PVCN exclu-
sively expressed VGLUT1&2, they can be ruled out completely as a 
source for the VGLUT2 terminals in IC. Most presumed terminals 
from the AVCN in the SOC contain both VGLUT1 and VGLUT2 
proteins (e.g., Billups, 2005).
functIonal consIderatIons
The present results demonstrate that different combinations of 
VGLUT gene expression are present in the auditory brainstem 
nuclei that project to the IC. This may be related to functional dif-
ferences in the pathways to the IC. The properties of the vesicular 
transporters of glutamate are very similar (Schafer et al., 2002; 
Varoqui et al., 2002); however, the vesicles that use VGLUT1 have 
two pathways for recycling vesicles, while those using VGLUT2 
or VGLUT3 only have one (Voglmaier et al., 2006). This suggests 
Figure 5 | Weak expression of VgLuT2 in layer 6 (Vi) of rostral 
auditory cortex in same case as Figure 4. Compared to Figure 4B, this 
section is developed to show weak expression and consequently some 
background labeling. Modest VGLUT2 expression is in layer 6 of ipsilateral 
cortex (A) and contralateral cortex (B), but it is weak compared to the 
thalamus of the same section (C). Labeling in layers 2/3 and 4 (II/III and IV) 
is slightly above background and less intense than layer 6. Lack of above 
background label in layer 5 suggests no FG+ neurons are VGLUT2 positive. 
Scale bar: 500 μm.Frontiers in Neuroanatomy  www.frontiersin.org  September 2010  | Volume 4  | Article 135  |  10
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that vesicles using VGLUT1 may recycle faster under prolonged, 
high-frequency stimuli. This ability to recycle faster may explain 
why the VGLUT1 synapses on hippocampal neurons depress more 
slowly than VGLUT2 synapses in response to high-frequency stimu-
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